Verastem, Inc. Files 8-K for Regulation FD Disclosure

Ticker: VSTM · Form: 8-K · Filed: Sep 8, 2025 · CIK: 1526119

Verastem, INC. 8-K Filing Summary
FieldDetail
CompanyVerastem, INC. (VSTM)
Form Type8-K
Filed DateSep 8, 2025
Risk Levellow
Pages1
Reading Time2 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: disclosure, financials

TL;DR

Verastem filed an 8-K on 9/8/25 for Reg FD disclosure & financials. All looks standard.

AI Summary

Verastem, Inc. filed an 8-K on September 8, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company's principal executive offices located at 117 Kendrick Street, Suite 500, Needham, MA 02494, with a business phone number of (781) 292-4200. Verastem, Inc. is incorporated in Delaware and operates in the Pharmaceutical Preparations industry.

Why It Matters

This 8-K filing provides an update on Verastem, Inc.'s regulatory disclosures and financial reporting, which is crucial for investors to stay informed about the company's compliance and financial status.

Risk Assessment

Risk Level: low — This filing is a routine 8-K for disclosures and exhibits, not indicating any immediate material adverse events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Verastem, Inc.?

The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to include Financial Statements and Exhibits.

When was this 8-K report filed by Verastem, Inc.?

This 8-K report was filed as of September 8, 2025.

Where are Verastem, Inc.'s principal executive offices located?

Verastem, Inc.'s principal executive offices are located at 117 Kendrick Street, Suite 500, Needham, MA 02494.

What is Verastem, Inc.'s telephone number?

Verastem, Inc.'s telephone number, including area code, is (781) 292-4200.

In which state is Verastem, Inc. incorporated?

Verastem, Inc. is incorporated in Delaware.

Filing Stats: 410 words · 2 min read · ~1 pages · Grade level 11.3 · Accepted 2025-09-08 07:01:09

Key Financial Figures

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure On September 8, 2025, Verastem, Inc. posted its updated corporate presentation on its website, a copy of which is furnished hereto as Exhibit 99.1 to this Current Report on Form 8-K.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits Exhibit No. Description 99.1 Corporate Presentation, dated September 8, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VERASTEM, INC. Dated: September 8, 2025 By: /s/ Daniel W. Paterson Daniel W. Paterson Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing